Humboldt Fund Asset Manager Profile - aVenture Research
Humboldt Fund is a venture capital firm focusing on early-stage biotech companies, particularly in synthetic biology. The fund invests in innovative startups working on transformative technologies in chemicals, materials, foods, and medicines. Humboldt Fund targets companies that combine engineering with physical and life sciences to address critical global issues.
Notable portfolio companies include Affini-T Therapeutics, Metagenomi, and Cellino. Humboldt Fund's investment philosophy centers on supporting visionary scientific synthesis and technological advances that disrupt global conventions. The firm is committed to creative problem-solving and backs companies poised to make significant impacts in trillion-dollar markets.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
